Aprea Therapeutics
APRE
#9813
Rank
ยฃ13.28 M
Marketcap
ยฃ2.44
Share price
-7.78%
Change (1 day)
-25.49%
Change (1 year)

Revenue for Aprea Therapeutics (APRE)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aprea Therapeutics from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ3.82 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.35 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.84 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA